Please check your internet connection and try again.
# Magnesium Sulfate
## Overview
Magnesium sulfate is an essential mineral that plays a vital role in various physiological processes, including neuromuscular function, cardiac excitability, and enzyme activity.
## Primary Indications
* Treatment of hypomagnesemia.
* Prevention and treatment of seizures in preeclampsia and eclampsia.
* Management of torsades de pointes.
* Bronchodilation in severe asthma exacerbations (off-label).
## Adult Dosing
* **Hypomagnesemia:**
* **Severe:** 4-6 grams (32-48 mEq) IV infusion over 4 hours, followed by a maintenance infusion of 1-2 grams (8-16 mEq) per hour as needed, based on serum magnesium levels.
* **Mild to Moderate:** 1-2 grams (8-16 mEq) IM every 4-6 hours for 3-4 doses, or IV infusion of 1 gram (8 mEq) per hour.
* **Preeclampsia/Eclampsia:** 4-6 grams (32-48 mEq) IV loading dose, followed by a maintenance infusion of 1-2 grams (8-16 mEq) per hour. IM dosing may be used in some protocols (e.g., 5 grams (40 mEq) IM in each buttock, followed by 5 grams (40 mEq) IM every 4 hours). Dosing varies by protocol.
* **Torsades de Pointes:** 1-2 grams (8-16 mEq) IV as a bolus over 5-10 minutes, followed by 0.5-1 gram (4-8 mEq) per hour infusion.
* **Asthma Exacerbation (Off-label):** 2 grams (16 mEq) IV infusion over 15-20 minutes.
## Pediatric Dosing
* **Hypomagnesemia:** Dosing is complex and depends on severity. Typical doses range from 25-50 mg/kg (elemental magnesium) per dose IV, not to exceed 2 grams (16 mEq) per dose. Maintenance infusions are often 0.2-0.5 mEq/kg/hr. Specific protocols should be consulted.
* **Preeclampsia/Eclampsia:** Limited data in pediatrics; generally similar to adult dosing if severe preeclampsia/eclampsia occurs.
* **Torsades de Pointes:** 25-50 mg/kg (elemental magnesium) IV, not to exceed 2 grams (16 mEq).
## Dose Adjustments
* **Renal Impairment:** Magnesium is renally excreted. Caution and reduced doses are necessary in patients with impaired renal function. Monitor magnesium levels closely.
## Contraindications
* Hypermagnesemia.
* Heart block greater than first degree and myocardial damage (in absence of adequate cardiac resuscitation facilities).
* Intended for IV use in patients with anuria or myocardial infarction.
## Adverse Effects
* **Common:** Flushing, sweating, nausea, vomiting, decreased deep tendon reflexes, hypotension, drowsiness.
* **Serious:** Respiratory depression, cardiac arrhythmias, cardiac arrest, hypermagnesemia (especially with renal impairment).
## Key Drug Interactions
* **Neuromuscular Blockers:** May potentiate neuromuscular blockade.
* **Calcium Salts:** May antagonize the cardiac effects of magnesium.
* **Tetracyclines, Bisphosphonates, Digoxin:** Oral magnesium can decrease absorption; separate administration by at least 2-3 hours.
## Monitoring
* **Serum Magnesium Levels:** Monitor frequently, especially during IV infusions and in patients with renal impairment. Therapeutic range for hypomagnesemia treatment is typically 2.5-4.5 mg/dL.
* **Renal Function:** Monitor creatinine and BUN.
* **Deep Tendon Reflexes:** Assess for loss of reflexes, an early sign of hypermagnesemia.
* **Respiratory Rate and Effort:** Monitor for signs of respiratory depression.
* **Cardiac Rhythm:** Monitor ECG, especially in patients receiving high doses or with underlying cardiac conditions.
## Clinical Pearls
* Magnesium sulfate is available in various concentrations (e.g., 10% - 1 gram/10 mL, 50% - 5 grams/10 mL). Ensure correct concentration is used for calculations.
* Extravasation can cause local irritation and tissue damage.
* Rapid IV infusion can lead to hypotension and cardiac depression.
* The antidote for severe magnesium toxicity is intravenous calcium (e.g., calcium gluconate).
***
**Disclaimer:** This information is intended for healthcare professionals and does not substitute for comprehensive clinical judgment. Always verify current prescribing information, institutional protocols, and patient-specific factors before administering any medication.
